MedTrace Logo

Mindfulness to Enhance Quality of Life and Support Advance Care Planning

NCT03257007 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2020-08-12

No results posted yet for this study

Summary

The MEANING trial is a randomized controlled mixed methods pilot designed to compare a novel mindfulness meditation-based intervention (MEANING) to usual care for adults with advanced-stage solid malignancies and their family caregivers.

Conditions

  • Mindfulness
  • Meditation
  • Metastatic Cancer
  • Quality of Life
  • Advance Care Planning
  • Palliative Care
  • Family Caregiver
  • Supportive Care

Interventions

BEHAVIORAL

Mindfulness

The Mindfulness intervention sessions are designed to cultivate present-moment awareness in everyday life to facilitate adaptive and non-reactive relating to thoughts, feelings, and bodily sensations. Participants will be provided with 10-20 minute audio recordings of each of 5 mindfulness practices covered in class, recorded in the facilitator's voice. Participants will be encouraged to practice mindfulness at home 10-20 minutes per day, 6 days per week. Participants will be provided with weekly diaries on which to record type and amount of home practice of mindfulness skills.

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Shelley A Johns, PsyD · Indiana University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-09
Primary Completion
2017-12-11
Completion
2017-12-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03257007 on ClinicalTrials.gov